Researcher

Lyudmila Bazhenova

University of California San Diego

2 developments in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

Latest

Everything in the corpus, newest first.

SEP 4, 2026 · JOURNAL ARTICLE

Characterizing Time Toxicity in Lung Cancer Clinical Trials: Development and Application of a Novel Time Burden Metric

JCO Oncology Practice

Descriptive analysis of protocol-derived metrics across historical trials with no patient-level validation, establishing feasibility of a novel measurement framework rather than testing clinical impact.

PreliminaryLyudmila Bazhenova Lisa Madlensky Sonia Jain

Reported

Median time toxicity (2005–2014)63.8

IQR time toxicity (2005–2014)41.8–109.3

Median time toxicity (2015–2024)82

AUG 17, 2026 · JOURNAL ARTICLE

Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2026.3.3

Journal of Clinical Oncology

This is an ASCO clinical practice guideline for stage IV NSCLC with driver alterations, systematically reviewed on an eight-week cycle by expert panel; it provides recommendations for clinical practice rather than reporting original research evidence.

Expert GuidanceLung Cancer Research Studies Lyudmila Bazhenova Terri Conneran